Our Story
A digital genetics platform grounded in research & collaboration
Genetics Adviser is the product of a decade of research and innovation
Designed to revolutionize the delivery of genetic health services through cutting-edge digital solutions. Collaborating with a community of genetic counselors, medical geneticists, patients, and digital health experts, our platform was developed to ensure a seamless, patient-centered experience while enhancing clinical efficiency.
Mission
To scale precision medicine as the trusted digital platform that adapts to the diverse needs of patients, healthcare providers and industry partners, facilitating high patient and clinician activation.
Vision
To be the trusted global leader in precision health services, making personalized care accessible and empowering millions.
“What makes Genetics Adviser unique as a clinical service is that it includes digital psychosocial support, delivered through a platform that has been validated over more than a decade.”
Our Key Values
Patient-Centric
We prioritize the needs and experiences of our patients, ensuring our products and services are designed to help them take control of their own health.
Collaborative Innovation
We work closely with clients, healthcare providers, and industry partners to deliver solutions that advance and improve access to precision medicine.
Empowerment
We empower patients and clinicians with accurate, evidence-based information, enabling and promoting personalized care.
Integrity and Trust
We uphold the highest standards through clinically validated, authentic, and ethical practices.
Improving Access
We are committed to meeting the diverse needs of all patients, ensuring equitable access to precision health services.
Genetics Adviser Founder and CEO, Dr. Yvonne Bombard, has over 15 years of expertise in researching the role of digital solutions in supporting the genetic testing process and advancing the delivery of genomics services.
Her extensive research has focused on the integration of digital tools to support clinical decision-making, their impact on the patient journey, and addressing the associated psychosocial, ethical, and equity challenges in genetic testing.
Alongside her co-founder, Marc Clausen, Dr. Bombard has contributed to numerous publications and clinical trials in collaboration with leading global industry partners.